Telesis Bio Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Telesis Bio.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Life Sciences earnings growth | 17.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
The Market Lifts Telesis Bio, Inc. (NASDAQ:TBIO) Shares 38% But It Can Do More
Apr 17
Codex DNA GAAP EPS of -$0.50, revenue of $5.7M; raises FY22 guidance
Aug 09Codex DNA, Inc. (NASDAQ:DNAY) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 25Pfizer's Codex DNA Deal Hints At Lucrative Pivot To mRNA - Keep An Eye On This Space
Jan 06Codex: Synthetic DNA/mRNA Instrument Developer Holds Impressive Upside In 2021
Sep 24In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Telesis Bio has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 20 | -51 | -23 | -22 | N/A |
| 3/31/2024 | 25 | -47 | -29 | -27 | N/A |
| 12/31/2023 | 28 | -49 | -37 | -35 | N/A |
| 9/30/2023 | 27 | -38 | -35 | -33 | N/A |
| 6/30/2023 | 28 | -39 | -45 | -42 | N/A |
| 3/31/2023 | 26 | -46 | -49 | -44 | N/A |
| 12/31/2022 | 27 | -48 | -43 | -39 | N/A |
| 9/30/2022 | 21 | -53 | -51 | -46 | N/A |
| 6/30/2022 | 17 | -50 | -48 | -43 | N/A |
| 3/31/2022 | 14 | -45 | -39 | -37 | N/A |
| 12/31/2021 | 11 | -39 | -39 | -37 | N/A |
| 9/30/2021 | 10 | -32 | -29 | -29 | N/A |
| 6/30/2021 | 9 | -27 | -20 | -20 | N/A |
| 3/31/2021 | 8 | -22 | -17 | -17 | N/A |
| 12/31/2020 | 7 | -18 | -16 | -15 | N/A |
| 12/31/2019 | 6 | -10 | -8 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if TBIO's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if TBIO's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if TBIO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if TBIO's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if TBIO's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TBIO's Return on Equity is forecast to be high in 3 years time